Sufficient Treatment of Peripheral Intervention by Cilostazol

Exclusion Criteria

• •Patients with or at risk of hemorrhagic complications or patients with bleeding tendency
• •Patients with congestive cardiac failure
• •Patients with a drug-eluting stent
• •Patients with acute lower limb ischemia
• •Patients with creatinine of 2 mg/dL or more(without dialysis)
• •patients with a history of serious adverse reaction such as leukopenia, hepatic dysfunction, or renal dysfunction, or hypersensitivity to any component of the study drug.
• •Lesion criteria:
• •Remnant inflow
• •Severe calcification
• •No arterial runoff below the knee